Literature DB >> 7001073

Hyperkalemia resulting from captopril administration.

S E Warren, D T O'Connor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7001073

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.

Authors:  Antonio Vukusich; Sonia Kunstmann; Cristian Varela; Daniela Gainza; Sebastian Bravo; Daniela Sepulveda; Gabriel Cavada; Luis Michea; Elisa T Marusic
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

Review 2.  Stopping and restarting medications in the perioperative period.

Authors:  R Cygan; H Waitzkin
Journal:  J Gen Intern Med       Date:  1987 Jul-Aug       Impact factor: 5.128

Review 3.  Safety profiles of the angiotensin-converting enzyme inhibitors.

Authors:  N J Warner; J E Rush
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

5.  Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.

Authors:  D V Hamilton; D B Evans; G Maidment; J S Pryor
Journal:  J R Soc Med       Date:  1981-05       Impact factor: 5.344

Review 6.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

7.  Evaluation of adverse effects of lisinopril and rosuvastatin on hematological and biochemical analytes in wistar rats.

Authors:  Hardik Dodiya; Vijay Kale; Sunita Goswami; Rajesh Sundar; Mukul Jain
Journal:  Toxicol Int       Date:  2013-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.